Global Pharmacovigilance Market Research Report 2026(Status and Outlook)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Pharmacovigilance market size was estimated at USD 5230.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pharmacovigilance market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pharmacovigilance market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pharmacovigilance market.
Global Pharmacovigilance Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Eli Lilly and Company
ICON
Elsevier
Chiltern
Atlantic Research Group
Mapi Group
Accenture
Clinquest Group
GSK
PRA Health Sciences
Market Segmentation (by Type)
Chemotherapy
Contract Outsourcing
Market Segmentation (by Application)
Pharma and Biotech Companies
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pharmacovigilance Market
Overview of the regional outlook of the Pharmacovigilance Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmacovigilance Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pharmacovigilance, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Pharmacovigilance market size was estimated at USD 5230.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pharmacovigilance market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pharmacovigilance market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pharmacovigilance market.
Global Pharmacovigilance Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Eli Lilly and Company
ICON
Elsevier
Chiltern
Atlantic Research Group
Mapi Group
Accenture
Clinquest Group
GSK
PRA Health Sciences
Market Segmentation (by Type)
Chemotherapy
Contract Outsourcing
Market Segmentation (by Application)
Pharma and Biotech Companies
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pharmacovigilance Market
Overview of the regional outlook of the Pharmacovigilance Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmacovigilance Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pharmacovigilance, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pharmacovigilance
1.2 Key Market Segments
1.2.1 Pharmacovigilance Segment by Type
1.2.2 Pharmacovigilance Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHARMACOVIGILANCE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pharmacovigilance Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Pharmacovigilance Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHARMACOVIGILANCE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pharmacovigilance Product Life Cycle
3.3 Global Pharmacovigilance Sales by Manufacturers (2020-2025)
3.4 Global Pharmacovigilance Revenue Market Share by Manufacturers (2020-2025)
3.5 Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pharmacovigilance Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Pharmacovigilance Market Competitive Situation and Trends
3.8.1 Pharmacovigilance Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pharmacovigilance Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PHARMACOVIGILANCE INDUSTRY CHAIN ANALYSIS
4.1 Pharmacovigilance Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHARMACOVIGILANCE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pharmacovigilance Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pharmacovigilance Market
5.7 ESG Ratings of Leading Companies
6 PHARMACOVIGILANCE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmacovigilance Sales Market Share by Type (2020-2025)
6.3 Global Pharmacovigilance Market Size by Type (2020-2025)
6.4 Global Pharmacovigilance Price by Type (2020-2025)
7 PHARMACOVIGILANCE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmacovigilance Market Sales by Application (2020-2025)
7.3 Global Pharmacovigilance Market Size (M USD) by Application (2020-2025)
7.4 Global Pharmacovigilance Sales Growth Rate by Application (2020-2025)
8 PHARMACOVIGILANCE MARKET SALES BY REGION
8.1 Global Pharmacovigilance Sales by Region
8.1.1 Global Pharmacovigilance Sales by Region
8.1.2 Global Pharmacovigilance Sales Market Share by Region
8.2 Global Pharmacovigilance Market Size by Region
8.2.1 Global Pharmacovigilance Market Size by Region
8.2.2 Global Pharmacovigilance Market Size by Region
8.3 North America
8.3.1 North America Pharmacovigilance Sales by Country
8.3.2 North America Pharmacovigilance Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pharmacovigilance Sales by Country
8.4.2 Europe Pharmacovigilance Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pharmacovigilance Sales by Region
8.5.2 Asia Pacific Pharmacovigilance Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pharmacovigilance Sales by Country
8.6.2 South America Pharmacovigilance Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pharmacovigilance Sales by Region
8.7.2 Middle East and Africa Pharmacovigilance Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PHARMACOVIGILANCE MARKET PRODUCTION BY REGION
9.1 Global Production of Pharmacovigilance by Region(2020-2025)
9.2 Global Pharmacovigilance Revenue Market Share by Region (2020-2025)
9.3 Global Pharmacovigilance Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pharmacovigilance Production
9.4.1 North America Pharmacovigilance Production Growth Rate (2020-2025)
9.4.2 North America Pharmacovigilance Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pharmacovigilance Production
9.5.1 Europe Pharmacovigilance Production Growth Rate (2020-2025)
9.5.2 Europe Pharmacovigilance Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pharmacovigilance Production (2020-2025)
9.6.1 Japan Pharmacovigilance Production Growth Rate (2020-2025)
9.6.2 Japan Pharmacovigilance Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pharmacovigilance Production (2020-2025)
9.7.1 China Pharmacovigilance Production Growth Rate (2020-2025)
9.7.2 China Pharmacovigilance Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Eli Lilly and Company
10.1.1 Eli Lilly and Company Basic Information
10.1.2 Eli Lilly and Company Pharmacovigilance Product Overview
10.1.3 Eli Lilly and Company Pharmacovigilance Product Market Performance
10.1.4 Eli Lilly and Company Business Overview
10.1.5 Eli Lilly and Company SWOT Analysis
10.1.6 Eli Lilly and Company Recent Developments
10.2 ICON
10.2.1 ICON Basic Information
10.2.2 ICON Pharmacovigilance Product Overview
10.2.3 ICON Pharmacovigilance Product Market Performance
10.2.4 ICON Business Overview
10.2.5 ICON SWOT Analysis
10.2.6 ICON Recent Developments
10.3 Elsevier
10.3.1 Elsevier Basic Information
10.3.2 Elsevier Pharmacovigilance Product Overview
10.3.3 Elsevier Pharmacovigilance Product Market Performance
10.3.4 Elsevier Business Overview
10.3.5 Elsevier SWOT Analysis
10.3.6 Elsevier Recent Developments
10.4 Chiltern
10.4.1 Chiltern Basic Information
10.4.2 Chiltern Pharmacovigilance Product Overview
10.4.3 Chiltern Pharmacovigilance Product Market Performance
10.4.4 Chiltern Business Overview
10.4.5 Chiltern Recent Developments
10.5 Atlantic Research Group
10.5.1 Atlantic Research Group Basic Information
10.5.2 Atlantic Research Group Pharmacovigilance Product Overview
10.5.3 Atlantic Research Group Pharmacovigilance Product Market Performance
10.5.4 Atlantic Research Group Business Overview
10.5.5 Atlantic Research Group Recent Developments
10.6 Mapi Group
10.6.1 Mapi Group Basic Information
10.6.2 Mapi Group Pharmacovigilance Product Overview
10.6.3 Mapi Group Pharmacovigilance Product Market Performance
10.6.4 Mapi Group Business Overview
10.6.5 Mapi Group Recent Developments
10.7 Accenture
10.7.1 Accenture Basic Information
10.7.2 Accenture Pharmacovigilance Product Overview
10.7.3 Accenture Pharmacovigilance Product Market Performance
10.7.4 Accenture Business Overview
10.7.5 Accenture Recent Developments
10.8 Clinquest Group
10.8.1 Clinquest Group Basic Information
10.8.2 Clinquest Group Pharmacovigilance Product Overview
10.8.3 Clinquest Group Pharmacovigilance Product Market Performance
10.8.4 Clinquest Group Business Overview
10.8.5 Clinquest Group Recent Developments
10.9 GSK
10.9.1 GSK Basic Information
10.9.2 GSK Pharmacovigilance Product Overview
10.9.3 GSK Pharmacovigilance Product Market Performance
10.9.4 GSK Business Overview
10.9.5 GSK Recent Developments
10.10 PRA Health Sciences
10.10.1 PRA Health Sciences Basic Information
10.10.2 PRA Health Sciences Pharmacovigilance Product Overview
10.10.3 PRA Health Sciences Pharmacovigilance Product Market Performance
10.10.4 PRA Health Sciences Business Overview
10.10.5 PRA Health Sciences Recent Developments
11 PHARMACOVIGILANCE MARKET FORECAST BY REGION
11.1 Global Pharmacovigilance Market Size Forecast
11.2 Global Pharmacovigilance Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pharmacovigilance Market Size Forecast by Country
11.2.3 Asia Pacific Pharmacovigilance Market Size Forecast by Region
11.2.4 South America Pharmacovigilance Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pharmacovigilance by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Pharmacovigilance Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Pharmacovigilance by Type (2026-2035)
12.1.2 Global Pharmacovigilance Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Pharmacovigilance by Type (2026-2035)
12.2 Global Pharmacovigilance Market Forecast by Application (2026-2035)
12.2.1 Global Pharmacovigilance Sales (K Units) Forecast by Application
12.2.2 Global Pharmacovigilance Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pharmacovigilance
1.2 Key Market Segments
1.2.1 Pharmacovigilance Segment by Type
1.2.2 Pharmacovigilance Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHARMACOVIGILANCE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pharmacovigilance Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Pharmacovigilance Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHARMACOVIGILANCE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pharmacovigilance Product Life Cycle
3.3 Global Pharmacovigilance Sales by Manufacturers (2020-2025)
3.4 Global Pharmacovigilance Revenue Market Share by Manufacturers (2020-2025)
3.5 Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pharmacovigilance Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Pharmacovigilance Market Competitive Situation and Trends
3.8.1 Pharmacovigilance Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pharmacovigilance Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PHARMACOVIGILANCE INDUSTRY CHAIN ANALYSIS
4.1 Pharmacovigilance Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHARMACOVIGILANCE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pharmacovigilance Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pharmacovigilance Market
5.7 ESG Ratings of Leading Companies
6 PHARMACOVIGILANCE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmacovigilance Sales Market Share by Type (2020-2025)
6.3 Global Pharmacovigilance Market Size by Type (2020-2025)
6.4 Global Pharmacovigilance Price by Type (2020-2025)
7 PHARMACOVIGILANCE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmacovigilance Market Sales by Application (2020-2025)
7.3 Global Pharmacovigilance Market Size (M USD) by Application (2020-2025)
7.4 Global Pharmacovigilance Sales Growth Rate by Application (2020-2025)
8 PHARMACOVIGILANCE MARKET SALES BY REGION
8.1 Global Pharmacovigilance Sales by Region
8.1.1 Global Pharmacovigilance Sales by Region
8.1.2 Global Pharmacovigilance Sales Market Share by Region
8.2 Global Pharmacovigilance Market Size by Region
8.2.1 Global Pharmacovigilance Market Size by Region
8.2.2 Global Pharmacovigilance Market Size by Region
8.3 North America
8.3.1 North America Pharmacovigilance Sales by Country
8.3.2 North America Pharmacovigilance Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pharmacovigilance Sales by Country
8.4.2 Europe Pharmacovigilance Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pharmacovigilance Sales by Region
8.5.2 Asia Pacific Pharmacovigilance Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pharmacovigilance Sales by Country
8.6.2 South America Pharmacovigilance Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pharmacovigilance Sales by Region
8.7.2 Middle East and Africa Pharmacovigilance Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PHARMACOVIGILANCE MARKET PRODUCTION BY REGION
9.1 Global Production of Pharmacovigilance by Region(2020-2025)
9.2 Global Pharmacovigilance Revenue Market Share by Region (2020-2025)
9.3 Global Pharmacovigilance Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pharmacovigilance Production
9.4.1 North America Pharmacovigilance Production Growth Rate (2020-2025)
9.4.2 North America Pharmacovigilance Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pharmacovigilance Production
9.5.1 Europe Pharmacovigilance Production Growth Rate (2020-2025)
9.5.2 Europe Pharmacovigilance Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pharmacovigilance Production (2020-2025)
9.6.1 Japan Pharmacovigilance Production Growth Rate (2020-2025)
9.6.2 Japan Pharmacovigilance Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pharmacovigilance Production (2020-2025)
9.7.1 China Pharmacovigilance Production Growth Rate (2020-2025)
9.7.2 China Pharmacovigilance Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Eli Lilly and Company
10.1.1 Eli Lilly and Company Basic Information
10.1.2 Eli Lilly and Company Pharmacovigilance Product Overview
10.1.3 Eli Lilly and Company Pharmacovigilance Product Market Performance
10.1.4 Eli Lilly and Company Business Overview
10.1.5 Eli Lilly and Company SWOT Analysis
10.1.6 Eli Lilly and Company Recent Developments
10.2 ICON
10.2.1 ICON Basic Information
10.2.2 ICON Pharmacovigilance Product Overview
10.2.3 ICON Pharmacovigilance Product Market Performance
10.2.4 ICON Business Overview
10.2.5 ICON SWOT Analysis
10.2.6 ICON Recent Developments
10.3 Elsevier
10.3.1 Elsevier Basic Information
10.3.2 Elsevier Pharmacovigilance Product Overview
10.3.3 Elsevier Pharmacovigilance Product Market Performance
10.3.4 Elsevier Business Overview
10.3.5 Elsevier SWOT Analysis
10.3.6 Elsevier Recent Developments
10.4 Chiltern
10.4.1 Chiltern Basic Information
10.4.2 Chiltern Pharmacovigilance Product Overview
10.4.3 Chiltern Pharmacovigilance Product Market Performance
10.4.4 Chiltern Business Overview
10.4.5 Chiltern Recent Developments
10.5 Atlantic Research Group
10.5.1 Atlantic Research Group Basic Information
10.5.2 Atlantic Research Group Pharmacovigilance Product Overview
10.5.3 Atlantic Research Group Pharmacovigilance Product Market Performance
10.5.4 Atlantic Research Group Business Overview
10.5.5 Atlantic Research Group Recent Developments
10.6 Mapi Group
10.6.1 Mapi Group Basic Information
10.6.2 Mapi Group Pharmacovigilance Product Overview
10.6.3 Mapi Group Pharmacovigilance Product Market Performance
10.6.4 Mapi Group Business Overview
10.6.5 Mapi Group Recent Developments
10.7 Accenture
10.7.1 Accenture Basic Information
10.7.2 Accenture Pharmacovigilance Product Overview
10.7.3 Accenture Pharmacovigilance Product Market Performance
10.7.4 Accenture Business Overview
10.7.5 Accenture Recent Developments
10.8 Clinquest Group
10.8.1 Clinquest Group Basic Information
10.8.2 Clinquest Group Pharmacovigilance Product Overview
10.8.3 Clinquest Group Pharmacovigilance Product Market Performance
10.8.4 Clinquest Group Business Overview
10.8.5 Clinquest Group Recent Developments
10.9 GSK
10.9.1 GSK Basic Information
10.9.2 GSK Pharmacovigilance Product Overview
10.9.3 GSK Pharmacovigilance Product Market Performance
10.9.4 GSK Business Overview
10.9.5 GSK Recent Developments
10.10 PRA Health Sciences
10.10.1 PRA Health Sciences Basic Information
10.10.2 PRA Health Sciences Pharmacovigilance Product Overview
10.10.3 PRA Health Sciences Pharmacovigilance Product Market Performance
10.10.4 PRA Health Sciences Business Overview
10.10.5 PRA Health Sciences Recent Developments
11 PHARMACOVIGILANCE MARKET FORECAST BY REGION
11.1 Global Pharmacovigilance Market Size Forecast
11.2 Global Pharmacovigilance Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pharmacovigilance Market Size Forecast by Country
11.2.3 Asia Pacific Pharmacovigilance Market Size Forecast by Region
11.2.4 South America Pharmacovigilance Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pharmacovigilance by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Pharmacovigilance Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Pharmacovigilance by Type (2026-2035)
12.1.2 Global Pharmacovigilance Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Pharmacovigilance by Type (2026-2035)
12.2 Global Pharmacovigilance Market Forecast by Application (2026-2035)
12.2.1 Global Pharmacovigilance Sales (K Units) Forecast by Application
12.2.2 Global Pharmacovigilance Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pharmacovigilance Market Size by Type (M USD)
Table 4. Global Pharmacovigilance Market Size by Application
Table 5. Pharmacovigilance Market Size Comparison by Region (M USD)
Table 6. Global Pharmacovigilance Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Pharmacovigilance Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pharmacovigilance Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pharmacovigilance Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance as of 2025)
Table 11. Global Market Pharmacovigilance Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Pharmacovigilance Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmacovigilance Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pharmacovigilance Sales by Type (K Units)
Table 27. Global Pharmacovigilance Market Size by Type (M USD)
Table 28. Global Pharmacovigilance Sales (K Units) by Type (2020-2025)
Table 29. Global Pharmacovigilance Sales Market Share by Type (2020-2025)
Table 30. Global Pharmacovigilance Market Size (M USD) by Type (2020-2025)
Table 31. Global Pharmacovigilance Market Share by Type (2020-2025)
Table 32. Global Pharmacovigilance Price (USD/Unit) by Type (2020-2025)
Table 33. Global Pharmacovigilance Sales (K Units) by Application
Table 34. Global Pharmacovigilance Market Size by Application
Table 35. Global Pharmacovigilance Sales by Application (2020-2025) & (K Units)
Table 36. Global Pharmacovigilance Sales Market Share by Application (2020-2025)
Table 37. Global Pharmacovigilance Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pharmacovigilance Market Share by Application (2020-2025)
Table 39. Global Pharmacovigilance Sales Growth Rate by Application (2020-2025)
Table 40. Global Pharmacovigilance Sales by Region (2020-2025) & (K Units)
Table 41. Global Pharmacovigilance Sales Market Share by Region (2020-2025)
Table 42. Global Pharmacovigilance Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pharmacovigilance Market Size by Region (2020-2025)
Table 44. North America Pharmacovigilance Sales by Country (2020-2025) & (K Units)
Table 45. North America Pharmacovigilance Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pharmacovigilance Sales by Country (2020-2025) & (K Units)
Table 47. Europe Pharmacovigilance Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pharmacovigilance Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Pharmacovigilance Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pharmacovigilance Sales by Country (2020-2025) & (K Units)
Table 51. South America Pharmacovigilance Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pharmacovigilance Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Pharmacovigilance Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pharmacovigilance Production (K Units) by Region(2020-2025)
Table 55. Global Pharmacovigilance Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pharmacovigilance Revenue Market Share by Region (2020-2025)
Table 57. Global Pharmacovigilance Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Pharmacovigilance Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Pharmacovigilance Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Pharmacovigilance Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Pharmacovigilance Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Eli Lilly and Company Basic Information
Table 63. Eli Lilly and Company Pharmacovigilance Product Overview
Table 64. Eli Lilly and Company Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Eli Lilly and Company Business Overview
Table 66. Eli Lilly and Company SWOT Analysis
Table 67. Eli Lilly and Company Recent Developments
Table 68. ICON Basic Information
Table 69. ICON Pharmacovigilance Product Overview
Table 70. ICON Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. ICON Business Overview
Table 72. ICON SWOT Analysis
Table 73. ICON Recent Developments
Table 74. Elsevier Basic Information
Table 75. Elsevier Pharmacovigilance Product Overview
Table 76. Elsevier Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Elsevier Business Overview
Table 78. Elsevier SWOT Analysis
Table 79. Elsevier Recent Developments
Table 80. Chiltern Basic Information
Table 81. Chiltern Pharmacovigilance Product Overview
Table 82. Chiltern Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Chiltern Business Overview
Table 84. Chiltern Recent Developments
Table 85. Atlantic Research Group Basic Information
Table 86. Atlantic Research Group Pharmacovigilance Product Overview
Table 87. Atlantic Research Group Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Atlantic Research Group Business Overview
Table 89. Atlantic Research Group Recent Developments
Table 90. Mapi Group Basic Information
Table 91. Mapi Group Pharmacovigilance Product Overview
Table 92. Mapi Group Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Mapi Group Business Overview
Table 94. Mapi Group Recent Developments
Table 95. Accenture Basic Information
Table 96. Accenture Pharmacovigilance Product Overview
Table 97. Accenture Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Accenture Business Overview
Table 99. Accenture Recent Developments
Table 100. Clinquest Group Basic Information
Table 101. Clinquest Group Pharmacovigilance Product Overview
Table 102. Clinquest Group Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Clinquest Group Business Overview
Table 104. Clinquest Group Recent Developments
Table 105. GSK Basic Information
Table 106. GSK Pharmacovigilance Product Overview
Table 107. GSK Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. GSK Business Overview
Table 109. GSK Recent Developments
Table 110. PRA Health Sciences Basic Information
Table 111. PRA Health Sciences Pharmacovigilance Product Overview
Table 112. PRA Health Sciences Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. PRA Health Sciences Business Overview
Table 114. PRA Health Sciences Recent Developments
Table 115. Global Pharmacovigilance Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Pharmacovigilance Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Pharmacovigilance Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Pharmacovigilance Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Pharmacovigilance Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Pharmacovigilance Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Pharmacovigilance Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Pharmacovigilance Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Pharmacovigilance Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Pharmacovigilance Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Pharmacovigilance Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Pharmacovigilance Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Pharmacovigilance Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Pharmacovigilance Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Pharmacovigilance Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Pharmacovigilance Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Pharmacovigilance Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pharmacovigilance Market Size by Type (M USD)
Table 4. Global Pharmacovigilance Market Size by Application
Table 5. Pharmacovigilance Market Size Comparison by Region (M USD)
Table 6. Global Pharmacovigilance Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Pharmacovigilance Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pharmacovigilance Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pharmacovigilance Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance as of 2025)
Table 11. Global Market Pharmacovigilance Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Pharmacovigilance Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmacovigilance Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pharmacovigilance Sales by Type (K Units)
Table 27. Global Pharmacovigilance Market Size by Type (M USD)
Table 28. Global Pharmacovigilance Sales (K Units) by Type (2020-2025)
Table 29. Global Pharmacovigilance Sales Market Share by Type (2020-2025)
Table 30. Global Pharmacovigilance Market Size (M USD) by Type (2020-2025)
Table 31. Global Pharmacovigilance Market Share by Type (2020-2025)
Table 32. Global Pharmacovigilance Price (USD/Unit) by Type (2020-2025)
Table 33. Global Pharmacovigilance Sales (K Units) by Application
Table 34. Global Pharmacovigilance Market Size by Application
Table 35. Global Pharmacovigilance Sales by Application (2020-2025) & (K Units)
Table 36. Global Pharmacovigilance Sales Market Share by Application (2020-2025)
Table 37. Global Pharmacovigilance Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pharmacovigilance Market Share by Application (2020-2025)
Table 39. Global Pharmacovigilance Sales Growth Rate by Application (2020-2025)
Table 40. Global Pharmacovigilance Sales by Region (2020-2025) & (K Units)
Table 41. Global Pharmacovigilance Sales Market Share by Region (2020-2025)
Table 42. Global Pharmacovigilance Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pharmacovigilance Market Size by Region (2020-2025)
Table 44. North America Pharmacovigilance Sales by Country (2020-2025) & (K Units)
Table 45. North America Pharmacovigilance Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pharmacovigilance Sales by Country (2020-2025) & (K Units)
Table 47. Europe Pharmacovigilance Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pharmacovigilance Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Pharmacovigilance Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pharmacovigilance Sales by Country (2020-2025) & (K Units)
Table 51. South America Pharmacovigilance Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pharmacovigilance Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Pharmacovigilance Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pharmacovigilance Production (K Units) by Region(2020-2025)
Table 55. Global Pharmacovigilance Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pharmacovigilance Revenue Market Share by Region (2020-2025)
Table 57. Global Pharmacovigilance Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Pharmacovigilance Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Pharmacovigilance Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Pharmacovigilance Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Pharmacovigilance Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Eli Lilly and Company Basic Information
Table 63. Eli Lilly and Company Pharmacovigilance Product Overview
Table 64. Eli Lilly and Company Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Eli Lilly and Company Business Overview
Table 66. Eli Lilly and Company SWOT Analysis
Table 67. Eli Lilly and Company Recent Developments
Table 68. ICON Basic Information
Table 69. ICON Pharmacovigilance Product Overview
Table 70. ICON Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. ICON Business Overview
Table 72. ICON SWOT Analysis
Table 73. ICON Recent Developments
Table 74. Elsevier Basic Information
Table 75. Elsevier Pharmacovigilance Product Overview
Table 76. Elsevier Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Elsevier Business Overview
Table 78. Elsevier SWOT Analysis
Table 79. Elsevier Recent Developments
Table 80. Chiltern Basic Information
Table 81. Chiltern Pharmacovigilance Product Overview
Table 82. Chiltern Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Chiltern Business Overview
Table 84. Chiltern Recent Developments
Table 85. Atlantic Research Group Basic Information
Table 86. Atlantic Research Group Pharmacovigilance Product Overview
Table 87. Atlantic Research Group Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Atlantic Research Group Business Overview
Table 89. Atlantic Research Group Recent Developments
Table 90. Mapi Group Basic Information
Table 91. Mapi Group Pharmacovigilance Product Overview
Table 92. Mapi Group Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Mapi Group Business Overview
Table 94. Mapi Group Recent Developments
Table 95. Accenture Basic Information
Table 96. Accenture Pharmacovigilance Product Overview
Table 97. Accenture Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Accenture Business Overview
Table 99. Accenture Recent Developments
Table 100. Clinquest Group Basic Information
Table 101. Clinquest Group Pharmacovigilance Product Overview
Table 102. Clinquest Group Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Clinquest Group Business Overview
Table 104. Clinquest Group Recent Developments
Table 105. GSK Basic Information
Table 106. GSK Pharmacovigilance Product Overview
Table 107. GSK Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. GSK Business Overview
Table 109. GSK Recent Developments
Table 110. PRA Health Sciences Basic Information
Table 111. PRA Health Sciences Pharmacovigilance Product Overview
Table 112. PRA Health Sciences Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. PRA Health Sciences Business Overview
Table 114. PRA Health Sciences Recent Developments
Table 115. Global Pharmacovigilance Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Pharmacovigilance Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Pharmacovigilance Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Pharmacovigilance Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Pharmacovigilance Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Pharmacovigilance Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Pharmacovigilance Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Pharmacovigilance Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Pharmacovigilance Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Pharmacovigilance Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Pharmacovigilance Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Pharmacovigilance Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Pharmacovigilance Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Pharmacovigilance Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Pharmacovigilance Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Pharmacovigilance Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Pharmacovigilance Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pharmacovigilance
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmacovigilance Market Size (M USD), 2025-2035
Figure 5. Global Pharmacovigilance Market Size (M USD) (2020-2035)
Figure 6. Global Pharmacovigilance Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmacovigilance Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pharmacovigilance Product Life Cycle
Figure 13. Pharmacovigilance Sales Share by Manufacturers in 2025
Figure 14. Global Pharmacovigilance Revenue Share by Manufacturers in 2025
Figure 15. Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pharmacovigilance Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pharmacovigilance Revenue in 2025
Figure 18. Industry Chain Map of Pharmacovigilance
Figure 19. Global Pharmacovigilance Market PEST Analysis
Figure 20. Global Pharmacovigilance Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pharmacovigilance Market Share by Type
Figure 27. Sales Market Share of Pharmacovigilance by Type (2020-2025)
Figure 28. Sales Market Share of Pharmacovigilance by Type in 2025
Figure 29. Market Share of Pharmacovigilance by Type (2020-2025)
Figure 30. Market Share of Pharmacovigilance by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pharmacovigilance Market Share by Application
Figure 33. Global Pharmacovigilance Sales Market Share by Application (2020-2025)
Figure 34. Global Pharmacovigilance Sales Market Share by Application in 2025
Figure 35. Global Pharmacovigilance Market Share by Application (2020-2025)
Figure 36. Global Pharmacovigilance Market Share by Application in 2025
Figure 37. Global Pharmacovigilance Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pharmacovigilance Sales Market Share by Region (2020-2025)
Figure 39. Global Pharmacovigilance Market Size by Region (2020-2025)
Figure 40. North America Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Pharmacovigilance Sales Market Share by Country in 2024
Figure 43. North America Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pharmacovigilance Market Size by Country in 2024
Figure 45. U.S. Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pharmacovigilance Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Pharmacovigilance Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pharmacovigilance Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pharmacovigilance Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Pharmacovigilance Sales Market Share by Country in 2024
Figure 53. Europe Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pharmacovigilance Market Size by Country in 2024
Figure 55. Germany Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pharmacovigilance Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Pharmacovigilance Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pharmacovigilance Market Size by Region in 2024
Figure 68. China Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pharmacovigilance Sales and Growth Rate (K Units)
Figure 79. South America Pharmacovigilance Sales Market Share by Country in 2024
Figure 80. South America Pharmacovigilance Market Size and Growth Rate (M USD)
Figure 81. South America Pharmacovigilance Market Size by Country in 2024
Figure 82. Brazil Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pharmacovigilance Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Pharmacovigilance Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pharmacovigilance Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pharmacovigilance Market Size by Region in 2024
Figure 92. Saudi Arabia Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pharmacovigilance Production Market Share by Region (2020-2025)
Figure 103. North America Pharmacovigilance Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Pharmacovigilance Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Pharmacovigilance Production (K Units) Growth Rate (2020-2025)
Figure 106. China Pharmacovigilance Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Pharmacovigilance Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Pharmacovigilance Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pharmacovigilance Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pharmacovigilance Market Share Forecast by Type (2026-2035)
Figure 111. Global Pharmacovigilance Sales Forecast by Application (2026-2035)
Figure 112. Global Pharmacovigilance Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Pharmacovigilance
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmacovigilance Market Size (M USD), 2025-2035
Figure 5. Global Pharmacovigilance Market Size (M USD) (2020-2035)
Figure 6. Global Pharmacovigilance Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmacovigilance Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pharmacovigilance Product Life Cycle
Figure 13. Pharmacovigilance Sales Share by Manufacturers in 2025
Figure 14. Global Pharmacovigilance Revenue Share by Manufacturers in 2025
Figure 15. Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pharmacovigilance Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pharmacovigilance Revenue in 2025
Figure 18. Industry Chain Map of Pharmacovigilance
Figure 19. Global Pharmacovigilance Market PEST Analysis
Figure 20. Global Pharmacovigilance Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pharmacovigilance Market Share by Type
Figure 27. Sales Market Share of Pharmacovigilance by Type (2020-2025)
Figure 28. Sales Market Share of Pharmacovigilance by Type in 2025
Figure 29. Market Share of Pharmacovigilance by Type (2020-2025)
Figure 30. Market Share of Pharmacovigilance by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pharmacovigilance Market Share by Application
Figure 33. Global Pharmacovigilance Sales Market Share by Application (2020-2025)
Figure 34. Global Pharmacovigilance Sales Market Share by Application in 2025
Figure 35. Global Pharmacovigilance Market Share by Application (2020-2025)
Figure 36. Global Pharmacovigilance Market Share by Application in 2025
Figure 37. Global Pharmacovigilance Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pharmacovigilance Sales Market Share by Region (2020-2025)
Figure 39. Global Pharmacovigilance Market Size by Region (2020-2025)
Figure 40. North America Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Pharmacovigilance Sales Market Share by Country in 2024
Figure 43. North America Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pharmacovigilance Market Size by Country in 2024
Figure 45. U.S. Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pharmacovigilance Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Pharmacovigilance Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pharmacovigilance Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pharmacovigilance Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Pharmacovigilance Sales Market Share by Country in 2024
Figure 53. Europe Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pharmacovigilance Market Size by Country in 2024
Figure 55. Germany Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pharmacovigilance Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Pharmacovigilance Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pharmacovigilance Market Size by Region in 2024
Figure 68. China Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pharmacovigilance Sales and Growth Rate (K Units)
Figure 79. South America Pharmacovigilance Sales Market Share by Country in 2024
Figure 80. South America Pharmacovigilance Market Size and Growth Rate (M USD)
Figure 81. South America Pharmacovigilance Market Size by Country in 2024
Figure 82. Brazil Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pharmacovigilance Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Pharmacovigilance Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pharmacovigilance Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pharmacovigilance Market Size by Region in 2024
Figure 92. Saudi Arabia Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pharmacovigilance Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Pharmacovigilance Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pharmacovigilance Production Market Share by Region (2020-2025)
Figure 103. North America Pharmacovigilance Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Pharmacovigilance Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Pharmacovigilance Production (K Units) Growth Rate (2020-2025)
Figure 106. China Pharmacovigilance Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Pharmacovigilance Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Pharmacovigilance Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pharmacovigilance Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pharmacovigilance Market Share Forecast by Type (2026-2035)
Figure 111. Global Pharmacovigilance Sales Forecast by Application (2026-2035)
Figure 112. Global Pharmacovigilance Market Share Forecast by Application (2026-2035)
